IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today’s precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy.
| Website | http://www.idrx.com |
| Employees | 9 (8 on RocketReach) |
| Industry | Biotechnology Research |
| Keywords | Precision Oncology, Cancer Therapies, Biopharmaceutical, Clinical Stage, Targeted Therapy, Drug Development, Cancer Research, Pharmaceutical Research, Oncology Research, New Drugs, Clinical Trials, Cancer Treatment, Biotechnology, Pharmaceutical, Health, Healthcare, Treatment |
| Competitors | Roche, Novartis, Merck & Co., Inc., Sanofi, Pfizer, AstraZeneca, Bristol Myers Squibb, Amgen, Gilead Sciences, Lilly India +42 more (view full list) |
Looking for a particular IDRx employee's phone or email?
IDRx Questions
Alexis Borisy is the Co-Founder of IDRx.
8 people are employed at IDRx.
Top IDRx Employees
-
Alexis Borisy
Co-Founder at IDRx
Boston, MA, US55 -
George Demetri
Co-Founder, IDRX (now GSK) at IDRx
Boston, MA, US34 -
5+5+
-
Debbie Johnson
Vice President Clinical Operations at IDRx
Boston, MA, US2 -
12
-
Elizabeth Campbell
Sr. Clinical Trial Manager at IDRx
Boston, MA, US35+ -
Jessica Christo
Chief Development Operations Officer at IDRx
Boston, MA, US12 -
Tayaramma T
Director, Statistical Programming at IDRx
Washington, DC, US
Related Companies
G2Crowd Trusted
300K+
Plugin Users
